Fatigue and headache often improve within the first month of treatment as the body adjusts to the medication
Retatrutide is a triagonist, or in other words, it activates multiple hormone receptors
The GLP-1 meal replacement market is segmented by Product Type (Ready-to-drink Shakes, Powder Meal Replacements, High-protein Nutrition Drinks, Soup and Savory Meal Replacements, Bar-based Meal Replacements), Nutritional Focus (High Protein, High Fiber, Low Sugar, Digestive Support, Micronutrient-fortified, Satiety-support Formulations), Consumer Stage (Active GLP-1 Users, Weight-maintenance Users, GLP-1 Step-down Users, General Weight-management Consumers), Distribution Channel (Pharmacies and Health Stores, Supermarkets and Hypermarkets, Direct-to-Consumer, E-commerce Marketplaces, Clinical and Wellness Channels), Pack Format (Single-serve Bottles, Sachets, Multi-serve Tubs, Ready Packs, Variety Packs), End Use (Breakfast Replacement, Lunch Replacement, Structured Weight-management Programs, Recovery Nutrition, On-the-go Consumption), and Region
Since GLP-1 receptors are also located in the brain, these medications may help support neuronal communication and reduce "neuro-inflammation." By helping the brain manage its energy supply better, they may indirectly help clear the metabolic "fog" caused by declining estrogen
A safer approach: PRP on day 1, GHK-Cu microneedling one week later
We offer the following two options for IV NAD+ infusion therapy: Cognitive enhancement/anti-aging infusion (500 mg NAD+)
